Philippines

Tuberculosis profile

| High TB burden | High MDR-TB burden |

Population 2013
Estimates of TB burden * 2013
Mortality (excludes HIV+TB)
Mortality (HIV+TB only)
Prevalence (includes HIV+TB)
Incidence (includes HIV+TB)
Incidence (HIV+TB only)
Case detection, all forms (%)
Estimates of MDR-TB burden * 2013
% of TB cases with MDR-TB
MDR-TB cases among notified pulmonary
TB cases

98 million
Number (thousands)
27 (2529)
0.058 (0.0420.077)
430 (380490)
290 (260330)
0.31 (0.180.34)
80 (7190)
New
2 (1.42.7)
4 400 (3 1006 000)

Rate
(per 100 000 population)
27 (2529)
0.06 (0.040.08)
438 (385495)
292 (261331)
0.32 (0.180.35)

Retreatment
21 (1629)

Total new and relapse

Previously treated, excluding relapses
Total cases notified

229 918
14 474
244 392

Treatment success rate

New cases registered in 2012
Previously treated cases registered in 2012
HIV-positive TB cases, all types, registered in 2012
RR-/MDR-TB cases started on second-line treatment in 2011
XDR-TB cases started on second-line treatment in 2011

20
0
1990

1994

1998

2002

2006

2010

2006

2010

1000

Relapse
4 669
0
0

500
0
1990

1994

1998

2002

Prevalence
(Rate per 100 000 population per year)
600
400

Among 97 221 new cases:

2 065 (2%) cases aged under 15 years; male:female ratio: 2.3

TB/HIV 2013
TB patients with known HIV status
HIV-positive TB patients
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)
HIV-positive TB patients on antiretroviral therapy (ART)
HIV-positive people screened for TB
HIV-positive people provided with IPT

40

(Rate per 100 000 population)

1500

4 100 (3 0005 500)

New **
97 353
123 510
4 386

New
3 137 (3%)

60

Mortality (excludes HIV+TB)

TB case notifications 2013

Pulmonary, bacteriologically confirmed
Pulmonary, clinically diagnosed
Extrapulmonary

Reported cases of RR-/MDR-TB 2013

Cases tested for RR-/MDR-TB
Laboratory-confirmed RR-/MDR-TB cases
Patients started on MDR-TB treatment

***
(Rate per 100 000 population per year)

200
Retreatment
13 419 (70%)

Number
5 034
26

Total **
17 241
3 962
2 262
(%)
(2)
(<1)

0
1990

1994

1998

2002

2006

Notified (new and relapse)

Incidence (HIV+TB only)

2010

Incidence

(Number of patients)
30
20
10
0
2003

3 006

2005

2007

2009

2011

HIV-positive TB patients
on CPT
on ART

(%)
88

Treatment success rate (%)

41
67

80
40

Laboratories 2013
Smear (per 100 000 population)
Culture (per 5 million population)
Drug susceptibility testing (per 5 million population)
Sites performing Xpert MTB/RIF
Is second-line drug susceptibility testing available?
Financing TB control 2014
National TB programme budget (US$ millions)
% Funded domestically
% Funded internationally
% Unfunded

2.6
0.9
0.2
16
Yes, in country

117
27%
25%
48%

0
1995 1997 1999 2001 2003 2005 2007 2009 2011
New
Retreatment
HIV-positive
RR-/MDR-TB

XDR-TB

Total budget (US$ millions)

150
100
50
0

* Ranges represent uncertainty intervals

** Includes cases with unknown previous TB treatment history

2010

__
__

2011

Funded domestically
Unfunded

Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
Generated: 2015-04-05

2012

__

2013

2014

Funded internationally

Data: www.who.int/tb/data